Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Natural Alternat. | -4.920% | -0.855% | -5.691% | -16.547% | 0.870% | -52.066% | -47.003% |
| Lumos Pharma Inc. | -4.960% | -4.255% | 7.143% | -8.784% | -7.534% | -74.286% | -79.239% |
| Erytech Pharma S.A. | -5.170% | - | - | - | - | - | - |
| Prescient Therapeutics Ltd. | -5.170% | - | - | - | - | - | - |
| Hexo Corp. | -5.340% | - | - | - | - | - | - |
| Lisata Therapeutics Inc. | -5.470% | -3.968% | -13.571% | -17.687% | -3.968% | -85.971% | -93.436% |
| Cara Therapeutics Inc. | -5.520% | -10.565% | -12.393% | -82.568% | -4.182% | -93.892% | -95.907% |
| Ironwood Pharmaceuticals | -5.560% | -20.134% | -19.595% | -36.022% | -41.667% | -37.696% | - |
| Akebia Therapeutics Inc. | -5.620% | -12.645% | -17.779% | 8.317% | -3.328% | -60.106% | - |
| Actinogen Ltd | -5.710% | -10.811% | -10.811% | -28.261% | 32.000% | -49.231% | 450.000% |
| XOMA Corp. | -5.830% | -1.739% | -6.612% | 34.524% | 33.728% | -8.130% | 69.593% |
| Bayer AG ADR | -5.960% | 1.429% | 0.000% | -46.617% | -17.442% | -49.645% | -48.551% |
| Mayne Pharma Group Ltd. | -6.070% | -8.636% | -5.189% | 73.276% | 6.915% | 1761.111% | 1019.777% |
| Forte Biosciences Inc. | -6.150% | -6.870% | -6.154% | -36.126% | -5.426% | -97.636% | - |
| Microbix Biosystems | -6.310% | - | - | - | - | - | - |
| Super League Gaming Inc | -6.540% | - | - | - | - | - | - |
| Palisade Bio Inc. | -6.680% | - | - | - | - | - | - |
| Alliance Pharma plc | -6.830% | 7.303% | -6.373% | -50.065% | -5.446% | -64.299% | - |
| vTv Therapeutics Inc | -6.980% | - | - | - | - | - | - |
| Genomic Vision S.A. | -7.140% | - | - | - | - | - | - |
| NanoViricides Inc. | -7.820% | 29.921% | 42.241% | 50.000% | 74.603% | -38.570% | -61.268% |
| Durect Corp. | -8.040% | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -8.050% | -3.303% | -5.710% | 99.690% | 64.076% | -77.404% | - |
| Curis Inc. | -8.090% | - | - | - | - | - | - |
| Prometic Life Sciences Inc. | -8.200% | - | - | - | - | - | - |